News Industry News CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI October 17, 2020
News Industry News Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference October 15, 2020
News Industry News CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial June 01, 2020